Increasing deal flow of projects ready for investment in the BioRegion: this is the main goal of the Investment Readiness Series, a new initiative from Biocat that periodically connects Catalan research projects with local and international investors. Some of the scientists participating in the first edition tell us about the projects they hope will enamor these investors.
Projects from the IRB, CRG, and UAB have been chosen in the latest edition of grants from the European Research Council (ERC), each worth up to €150,000. Catalonia swept 10% of the total grants awarded to researchers from all over Europe and 5 of the 7 grants awarded to Spanish entities.
Who will pay for my product? Who can kill it? How do I approach investors? What happens if I fail? Experts from CIMIT (Boston), the most experienced health accelerator in the world, share some of the lessons they’ve learned accelerating more than 600 healthtech projects in 15 years.
